vs

Side-by-side financial comparison of Playboy, Inc. (PLBY) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.

Playboy, Inc. is the larger business by last-quarter revenue ($34.9M vs $18.3M, roughly 1.9× ROCKWELL MEDICAL, INC.). Playboy, Inc. runs the higher net margin — 10.3% vs -3.0%, a 13.3% gap on every dollar of revenue. On growth, Playboy, Inc. posted the faster year-over-year revenue change (4.2% vs -25.6%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $1.1M). Over the past eight quarters, Playboy, Inc.'s revenue compounded faster (11.0% CAGR vs -10.1%).

Playboy is an American men's lifestyle and entertainment magazine, available both online and in print. It was founded in Chicago in 1953 by Hugh Hefner and his associates, funded in part by a $1,000 loan from Hefner's mother.

Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).

PLBY vs RMTI — Head-to-Head

Bigger by revenue
PLBY
PLBY
1.9× larger
PLBY
$34.9M
$18.3M
RMTI
Growing faster (revenue YoY)
PLBY
PLBY
+29.9% gap
PLBY
4.2%
-25.6%
RMTI
Higher net margin
PLBY
PLBY
13.3% more per $
PLBY
10.3%
-3.0%
RMTI
More free cash flow
RMTI
RMTI
$1.1M more FCF
RMTI
$2.2M
$1.1M
PLBY
Faster 2-yr revenue CAGR
PLBY
PLBY
Annualised
PLBY
11.0%
-10.1%
RMTI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PLBY
PLBY
RMTI
RMTI
Revenue
$34.9M
$18.3M
Net Profit
$3.6M
$-554.0K
Gross Margin
73.3%
21.1%
Operating Margin
7.9%
-2.2%
Net Margin
10.3%
-3.0%
Revenue YoY
4.2%
-25.6%
Net Profit YoY
128.6%
26.7%
EPS (diluted)
$0.05
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PLBY
PLBY
RMTI
RMTI
Q4 25
$34.9M
$18.3M
Q3 25
$29.0M
$15.9M
Q2 25
$28.1M
$16.1M
Q1 25
$28.9M
$18.9M
Q4 24
$33.5M
$24.7M
Q3 24
$29.4M
$28.3M
Q2 24
$24.9M
$25.8M
Q1 24
$28.3M
$22.7M
Net Profit
PLBY
PLBY
RMTI
RMTI
Q4 25
$3.6M
$-554.0K
Q3 25
$460.0K
$-1.8M
Q2 25
$-7.7M
$-1.5M
Q1 25
$-9.0M
$-1.5M
Q4 24
$-12.5M
$-756.0K
Q3 24
$-33.8M
$1.7M
Q2 24
$-16.7M
$343.0K
Q1 24
$-16.4M
$-1.7M
Gross Margin
PLBY
PLBY
RMTI
RMTI
Q4 25
73.3%
21.1%
Q3 25
76.0%
14.3%
Q2 25
65.4%
15.6%
Q1 25
68.6%
16.1%
Q4 24
70.8%
14.7%
Q3 24
61.0%
22.0%
Q2 24
67.8%
17.6%
Q1 24
55.8%
13.5%
Operating Margin
PLBY
PLBY
RMTI
RMTI
Q4 25
7.9%
-2.2%
Q3 25
4.7%
-9.9%
Q2 25
-20.9%
-8.4%
Q1 25
-21.7%
-7.2%
Q4 24
-13.3%
-2.1%
Q3 24
-96.0%
6.8%
Q2 24
-37.0%
2.0%
Q1 24
-31.5%
-5.8%
Net Margin
PLBY
PLBY
RMTI
RMTI
Q4 25
10.3%
-3.0%
Q3 25
1.6%
-11.0%
Q2 25
-27.3%
-9.3%
Q1 25
-31.3%
-8.0%
Q4 24
-37.4%
-3.1%
Q3 24
-114.7%
5.9%
Q2 24
-66.9%
1.3%
Q1 24
-58.1%
-7.6%
EPS (diluted)
PLBY
PLBY
RMTI
RMTI
Q4 25
$0.05
$-0.01
Q3 25
$0.00
$-0.05
Q2 25
$-0.08
$-0.05
Q1 25
$-0.10
$-0.04
Q4 24
$-0.13
$-0.02
Q3 24
$-0.45
$0.04
Q2 24
$-0.23
$0.01
Q1 24
$-0.23
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PLBY
PLBY
RMTI
RMTI
Cash + ST InvestmentsLiquidity on hand
$37.8M
$10.7M
Total DebtLower is stronger
$174.2M
Stockholders' EquityBook value
$18.4M
$37.0M
Total Assets
$292.4M
$57.1M
Debt / EquityLower = less leverage
9.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PLBY
PLBY
RMTI
RMTI
Q4 25
$37.8M
$10.7M
Q3 25
$27.5M
$13.6M
Q2 25
$19.6M
$12.5M
Q1 25
$23.7M
$11.4M
Q4 24
$30.9M
$15.7M
Q3 24
$9.5M
$12.3M
Q2 24
$16.9M
$11.9M
Q1 24
$19.0M
$6.6M
Total Debt
PLBY
PLBY
RMTI
RMTI
Q4 25
$174.2M
Q3 25
$176.8M
Q2 25
$177.5M
Q1 25
$176.3M
Q4 24
$176.6M
Q3 24
$200.0M
Q2 24
$196.3M
Q1 24
$193.4M
Stockholders' Equity
PLBY
PLBY
RMTI
RMTI
Q4 25
$18.4M
$37.0M
Q3 25
$3.8M
$37.0M
Q2 25
$-17.5M
$30.4M
Q1 25
$-11.4M
$31.5M
Q4 24
$-7.7M
$32.6M
Q3 24
$-15.7M
$29.1M
Q2 24
$15.7M
$23.5M
Q1 24
$29.5M
$20.6M
Total Assets
PLBY
PLBY
RMTI
RMTI
Q4 25
$292.4M
$57.1M
Q3 25
$278.3M
$57.5M
Q2 25
$264.1M
$52.6M
Q1 25
$270.6M
$54.0M
Q4 24
$284.7M
$59.2M
Q3 24
$271.5M
$57.1M
Q2 24
$301.8M
$53.0M
Q1 24
$309.1M
$50.7M
Debt / Equity
PLBY
PLBY
RMTI
RMTI
Q4 25
9.48×
Q3 25
46.86×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
12.51×
Q1 24
6.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PLBY
PLBY
RMTI
RMTI
Operating Cash FlowLast quarter
$1.4M
$2.3M
Free Cash FlowOCF − Capex
$1.1M
$2.2M
FCF MarginFCF / Revenue
3.2%
12.0%
Capex IntensityCapex / Revenue
0.8%
0.5%
Cash ConversionOCF / Net Profit
0.39×
TTM Free Cash FlowTrailing 4 quarters
$-1.0M
$-1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PLBY
PLBY
RMTI
RMTI
Q4 25
$1.4M
$2.3M
Q3 25
$10.1M
$-1.3M
Q2 25
$-3.9M
$1.8M
Q1 25
$-7.6M
$-3.5M
Q4 24
$161.0K
$865.0K
Q3 24
$-6.5M
$4.3M
Q2 24
$-3.0M
$1.4M
Q1 24
$-9.8M
$-2.4M
Free Cash Flow
PLBY
PLBY
RMTI
RMTI
Q4 25
$1.1M
$2.2M
Q3 25
$9.8M
$-1.5M
Q2 25
$-4.3M
$1.7M
Q1 25
$-7.7M
$-3.5M
Q4 24
$-401.0K
$470.0K
Q3 24
$-7.0M
$4.1M
Q2 24
$-3.7M
$1.2M
Q1 24
$-10.3M
$-2.5M
FCF Margin
PLBY
PLBY
RMTI
RMTI
Q4 25
3.2%
12.0%
Q3 25
33.8%
-9.6%
Q2 25
-15.2%
10.5%
Q1 25
-26.5%
-18.8%
Q4 24
-1.2%
1.9%
Q3 24
-23.7%
14.4%
Q2 24
-14.8%
4.5%
Q1 24
-36.5%
-11.1%
Capex Intensity
PLBY
PLBY
RMTI
RMTI
Q4 25
0.8%
0.5%
Q3 25
1.1%
1.4%
Q2 25
1.4%
1.0%
Q1 25
0.1%
0.3%
Q4 24
1.7%
1.6%
Q3 24
1.5%
0.7%
Q2 24
2.6%
1.1%
Q1 24
2.1%
0.6%
Cash Conversion
PLBY
PLBY
RMTI
RMTI
Q4 25
0.39×
Q3 25
22.02×
Q2 25
Q1 25
Q4 24
Q3 24
2.57×
Q2 24
4.20×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PLBY
PLBY

Transferred At Point In Time$22.2M64%
Trademark Licensing$6.5M19%
Related Party$5.0M14%
Other$1.1M3%

RMTI
RMTI

US$15.9M87%
Non Us$2.4M13%

Related Comparisons